Flexus Biosciences Secures $38,000,000 Series B Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=21afc7ff-f6c2-4d76-b2a6-6cf822445e4d
Date
12/19/2014
Company Name
Flexus Biosciences
Mailing Address
75 Shoreway Road San Carlos, CA 94070 USA
Company Description
Founded with the mission to create new cancer therapeutics through an innovative application of unexploited insights in immunology.
Website
http://www.flexusbio.com
Transaction Type
Venture Equity
Transaction Amount
$38,000,000
Transaction Round
Series B
Proceeds Purposes
The company is now well positioned to advance its pipeline of immunotherapies and to select a clinical candidate from its IDO-1 inhibitor program in early 2015.
M&A Terms
Venture Investor
Venture Investor
Venture Investor